An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day ...
Type C Meeting Requested to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, Feb. 24, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc.
Political and business leaders are rethinking AI—as not just a technology to regulate but as a force to accelerate. Medicine ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesKey biosimilar value driver contributes to Sandoz global growth strategy ...